ARTICLE | Distillery Therapeutics
Therapeutics: Transient receptor potential cation channel subfamily M member 2 (TRPM2)
January 7, 2016 8:00 AM UTC
In vitro and mouse studies suggest inhibiting TRPM2 could help treat AD. In mouse hippocampal neurons, β-amyloid oligomers increased TRPM2 activity compared with no treatment. In a mouse model of AD, ...